Allied Market Research
Upcoming Allied Market Research
Platelet And Plasma Market

Platelet and Plasma Market: Global Opportunity Analysis and Industry Forecast, 2020-2027

Pages: NA
Dec 2021 | 314 Views
Author(s) : Onkar Sumant
Tables: NA
Charts: NA
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.



Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Platelet And Plasma Market

Request Now !

Platelet and Plasma Market Outlook - 2027

Human blood contains many chemical substances, primarily platelets, red blood cells, white blood cells and plasma. Platelet-rich plasma, also called PRP, is the part of the blood sample that includes mostly platelets and pure plasma, leaving out both the red and white blood cells. Platelet-poor plasma (PPP), as the name indicates, is similar to PRP in one way: it contains plasma. However, PPP contains almost no platelets. When collected and prepared correctly, human blood yields both PRP and PPP. Both platelet-poor plasma and platelet-rich plasma serve important functions in medical science. Both are used in the field of regenerative medicine. In areas as diverse as physical medicine, rheumatology, rehab and orthopedics, PRP and PPP therapy are used to speed up the human body’s natural healing process.

Platelet and plasma market scope and structural analysis:

Report Metric


  Market size available for years


  Base year considered 


  Forecast period


  Forecast units

  Value (USD)

  Segments covered

  Type, Application, End-users, Region.

  Regions covered

•North America (U.S., Canada, Mexico)

•Europe (France, Germany, UK, Italy, Spain, Rest of Europe)

•Asia-Pacific (Japan, China, India, Australia, South Korea, Rest of Asia-Pacific)

•LAMEA (Brazil, South Arabia, South Africa, Rest of LAMEA)

  Companies covered

T-Biotechnology (T-LAB); Arthrex, Inc.; Terumo BCT, Inc.; EmCyte Corporation; DePuy Synthes; Zimmer Biomet; Stryker; Glofinn Oy; DR. PRP AMERICA, LLC;

Covid-19 Scenario analysis:

The deadly coronavirus outbreak continues to spread worldwide with the number of positive cases and deaths rising expeditiously daily. The number of confirmed cases has touched the mark of 3.76 million with no signs of slowing down. Several vaccination trials are underway in different parts of the world. India is pitching plasma therapy as an effective mode of treatment. Country’s top medical research organization, Indian Council of Medical Research (ICMR), is framing a protocol to jump start this process. Convalescent plasma therapy is based on the concept of passive immunity, where antibodies of some disease developed in a person are used for treating others. Plasma in the blood contains antibodies, which helps to fight foreign pathogens. Once they have dealt with a certain kind of foreign element, some blood cells act as a memory cell and store information. When they come in contact with the same kind of pathogens again they identify and defect it quickly by producing the same antibodies. Hence the plasma market will see a boost during the pandemic as there is an increased need in the market.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact analysis:


Multiple application of the PRP and PPP:

Platelet-rich plasma has several uses, all of which are derived from the substance’s high concentration of growth factors. These growth-enhancing chemicals are thought to greatly speed up the process of tissue repair in the human body. Platelets are also able to ramp up production of various types of fibroblasts, which is another assistive factor in healing process. Treatment with PRP appears to revive tendons that have been injured, attract blood to sites of injury, help with new cell recruitment, speed up growth of blood vessels, boost the nutritional profile of injury sites and generally promote healthful metabolic processes. Most of the known benefits of PRP therapy have been clearly demonstrated in animal studies by researchers who set out to test the efficacy of the treatment.

Platelet-poor plasma has a profound role in numerous medical treatments. One of the first known uses of PPP was in studies focused on platelet aggregation. Not only is PPP used as a scientific experiment control but it also serves as a precise mechanism to calibrate the concentrations of platelet-rich plasma samples. If, for example, a particular PRP sample contains too many platelets for a given treatment regimen, PPP can be added in specific amounts that render the PRP sample to be of the correct concentration. Additionally, PPP serves in its own right as a healing agent. Because PPP is thought to contain very high levels of fibrinogen, an agent known to speed up the healing of wounds. In cosmetic surgery, too, PPP plays a role. As a so-called “fibrin sealant,” PPP is currently utilized in orthopedic surgery, blood management and cosmetic surgery. One of the most advantageous aspects of PPP treatments is the fact that platelet-poor plasma is an abundant by-product in the preparation of PRP.

Regional and Market analysis:

According to the American Academy of Neurology, plasma can be used for the treatment of various neurological conditions. Plasma exchange process involves replacing plasma in a person’s blood. This process can be used for the treatment of conditions such as inflammatory dis-immune neuropathies, multiple sclerosis, myasthenia gravis, and other disorders will accelerate industry growth during the forecast period. Increasing blood transfusion rates in Europe will drive the platelet and plasma market growth over the forecast period. Blood transfusion process is primarily done to isolate the desired blood components such as red blood cells, plasma, platelets and other vital components of the blood. Government initiatives to create awareness regarding source plasma collection, as well as the use of lifesaving plasma protein therapies in rare diseases, will positively impact the market growth. Advancements in healthcare infrastructure coupled with the increasing number of blood transfusions will directly impact the growth of Platelet, Plasma Market in the coming years. The advent of technologically advanced platelet and plasma products is another major driver that will augment the market growth. Use of platelets and plasma in the treatment of rare, debilitating, life-threatening conditions and chronic diseases such as Hepatitis B heavily influences the growth of the market. Plasma-derived from blood can be used in treating rare diseases wherein no other alternative treatment is available. For instance, use of plasma for treatment of Ebola virus during its outbreak in West Africa. These factors are projected to augment the market growth during the forecast period.


The main indication for the transfusion of plasma is to correct deficiencies of clotting factors, for which a specific concentrate is not available, in patients with active bleeding. The products available are: fresh-frozen plasma (FFP), plasma that has undergone viral inactivation with solvent/detergent treatment (S/D FFP), with methylene blue (MB FFP) or with psoralens, in particular amotosalen (S59) and light; inactivation technology using riboflavin will soon be available until than this will hamper market.

Key segments covered:




  • Pure PRP
  • Leukocyte Rich PRP
  • Leukocyte Rich Fibrin
  • Platelet poor plasma PPP


  • Orthopedics
  • Cosmetic Surgery & Dermatology
  • Ophthalmic Surgery
  • Neurosurgery
  • General surgery
  • Others

  End User

  • Research laboratories
  • Hospitals
  • Diagnostic centers
  • Others


  • North America
  • Europe
  • Asia-Pacific


Key benefits of the report:

  • This study presents the analytical depiction of the global Platelet and Plasma industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global Platelet and Plasma market share.
  • The current market is quantitatively analyzed from 2020 to 2027 to highlight the global Platelet and Plasma market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global Platelet and Plasma market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Platelet and Plasma Market research report:

  • What are the leading market players active in the Platelet and Plasma market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Start reading ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

Toll-free :
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email :
Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.










Purchase Full Report of
Platelet And Plasma Market

Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456  $3,110
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769  $5,192
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $5,805
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise

  • $9,995  $8,996
  • Unlimited
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers


Featured Reports


Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings


Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers